Short answer
Definitive Healthcare Corp. (DH) filed an 8-K current report with the SEC on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 financial results announced for quarter ended September 30, 2026.
Definitive Healthcare Corp. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 2026 financial results announced for quarter ended September 30, 2026
- Definitive Healthcare’s detailed results and management commentary are in Exhibit 99.1
- Results announcement provides updated investor visibility into quarterly operating performance
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $54.7M, down 9% YoY, signaling continued top-line pressure despite customer wins and expansion activity
- Net loss narrowed to $5.4M from $17.8M, while adjusted EBITDA fell to $15.7M from $18.9M
- Adjusted EBITDA margin compressed to 29% from 32%, indicating weaker operating leverage
- Operating cash flow $11.4M and unlevered free cash flow $13.0M, supporting liquidity with cash of $177.1M
- Advent’s non-binding acquisition interest removes financial guidance and the earnings call, making deal execution the primary near-term catalyst
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Definitive Healthcare Corp. 8-K filings
Get the next DH 8-K as it lands
Follow DH for push alerts, or ask the research agent what this filing means.